BackDMK Pharmaceuticals Overview

DMK Pharmaceuticals Net Tangible Assets

DMK Pharmaceuticals's net tangible assets is $-5B.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$-4.96B
↓ 174577.82% YoYΔ $-4.97B vs prior year quarter

Peer trimmed avg / median

Loading

DMK Pharmaceuticals Net Tangible Assets History

Loading

DMK Pharmaceuticals vs. peers: Net Tangible Assets Comparison

Loading

DMK Pharmaceuticals Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

DMK Pharmaceuticals (DMKPQ) FAQ

The latest net tangible assets for DMKPQ is $-5B as of September 2023. That compares with $2.8M in the prior-year period — down 174577.8% year over year. Investors often review this figure alongside DMK Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, DMKPQ's net tangible assets moved from $2.8M to $-5B — a 174577.8% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in DMK Pharmaceuticals's operating scale or balance-sheet position.

A net tangible assets figure of $-5B for DMKPQ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting DMKPQ's net tangible assets ($-5B), review year-over-year change from $2.8M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack DMK Pharmaceuticals's net tangible assets against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.